Vilma Dembitz

发表

5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells

H. Lalić, Vilma Dembitz, V. Lukinović-Škudar, 2014, Leukemia & lymphoma.

5-Aminoimidazole-4-carboxamide ribonucleoside-induced autophagy flux during differentiation of monocytic leukemia cells

H. Lalić, Vilma Dembitz, D. Visnjic, 2017, Cell Death Discovery.

Inositol pyrophosphates modulate cell cycle independently of alteration in telomere length.

H. Lalić, Vilma Dembitz, V. Lukinović-Škudar, 2016, Advances in biological regulation.

An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis

Z. Estrov, H. Kantarjian, T. Manshouri, 2017, Haematologica.

Mannose metabolism inhibition sensitizes acute myeloid leukemia cells to cytarabine and FLT3 inhibitor therapy by modulating fatty acid metabolism to drive ferroptotic cell death

Pedro Madrigal, B. Huntly, G. Vassiliou, 2022, bioRxiv.

AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review

H. Lalić, Vilma Dembitz, D. Visnjic, 2021, Cells.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts

H. Lalić, Vilma Dembitz, D. Visnjic, 2020, BMC Cancer.

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion

J. Simon, Vilma Dembitz, D. Visnjic, 2019, The Journal of Biological Chemistry.

All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16

H. Lalić, Vilma Dembitz, D. Visnjic, 2021, International Journal of Hematology.

The role of AMPK/mTOR modulators in therapy of acute myeloid leukemia.

H. Lalić, Vilma Dembitz, D. Visnjic, 2018, Current medicinal chemistry.

Mannose metabolism inhibition sensitizes acute myeloid leukemia cells to cytarabine and FLT3 inhibitor therapy by modulating fatty acid metabolism to drive ferroptotic cell death

Pedro Madrigal, B. Huntly, G. Vassiliou, 2023, bioRxiv.

The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia

P. Gallipoli, Vilma Dembitz, 2021, Frontiers in Oncology.

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

H. Lalić, Vilma Dembitz, D. Visnjic, 2022, Scientific Reports.

The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation

R. Vrhovac, H. Lalić, Vilma Dembitz, 2015, International Journal of Hematology.

Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death

Pedro Madrigal, B. Huntly, G. Vassiliou, 2023, Nature communications.

Metabolism and differentiation

H. Lalić, Vilma Dembitz, H. Banfić, 2014 .

C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia.

A. Dejean, B. Colsch, M. Carroll, 2023, Cancer discovery.

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

H. Lalić, Vilma Dembitz, D. Visnjic, 2022, Scientific Reports.

SCD inhibition eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy

A. von Kriegsheim, J. Fitzgibbon, J. Tamburini, 2023, bioRxiv.

SCD inhibition preferentially eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy

A. von Kriegsheim, J. Fitzgibbon, J. Tamburini, 2023, bioRxiv.

An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis

Z. Estrov, H. Kantarjian, T. Manshouri, 2017, Haematologica.

Combined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells

Vilma Dembitz, H. Banfić, D. Visnjic, 2011, Pathology & Oncology Research.

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia

H. Lalić, Vilma Dembitz, D. Visnjic, 2023, Frontiers in pharmacology.

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.

B. Peck, J. Schwaller, P. Casado, 2024, Leukemia.